Αποτελέσματα Αναζήτησης
10 Ιουν 2021 · To combat the threat of animal-to-human transmission, and the rise of mutant variants, Russian researchers from the Federal Service for Veterinary and Phytosanitary Surveillance have developed the first COVID-19 vaccine (Carnivac-Cov) for animals. The vaccine, also known as Karnivak-Kov, has been designed for carnivores (Figure 1).
- Figure - PMC - National Center for Biotechnology Information
Schematic illustration of the live-inactivated SARS-CoV-2...
- A COVID-19 Vaccine for Dogs Prevents Reverse Zoonosis
To counteract reverse zoonosis, we developed the first...
- Figure - PMC - National Center for Biotechnology Information
24 Απρ 2022 · To counteract reverse zoonosis, we developed the first COVID-19 subunit vaccines for dogs, which are representative companion animals, and the vaccine includes the SARS-CoV-2 recombinant protein of whole S1 protein and the receptor-binding domain (RBD).
12 Δεκ 2021 · Abstract. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already affected millions worldwide. The emergence of multiple SARS-CoV-2 variants may pose a significant threat to our efforts in controlling the pandemic.
17 Ιουν 2021 · The COVID-19 pandemic response leveraged these innovations to enable rapid development of candidate vaccines within weeks of the viral genetic sequence being made available. The development...
24 Απρ 2022 · To counteract reverse zoonosis, we developed the first COVID-19 subunit vaccines for dogs, which are representative companion animals, and the vaccine includes the SARS-CoV-2 recombinant protein of whole S1 protein and the receptor-binding domain (RBD).
23 Σεπ 2020 · As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence...
19 Μαρ 2024 · Vaccination programs have proven to be effective in controlling coronaviruses infections, offering a cost-effective approach to reducing morbidity and mortality, so the re-emergence of lethal coronaviruses emphasizes the urgent need for the development of effective vaccines.
